Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 301–400 of 1,000
Shen, M., Quertermous, T., Fischbein, M. P., & Wu, J. C. (2021) · Circulation Research · doi:10.1161/circresaha.120.318049 · Cited by 80
Epigenetic Modifications of Stem Cells: A Paradigm for the Control of Cardiac Progenitor Cells
Zhou, Y., Kim, J., Yuan, X., & Braun, T. W. (2011) · Circulation Research · doi:10.1161/circresaha.111.243709 · Cited by 87
Burridge, P. W., Sharma, A., & Wu, J. C. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054911 · Cited by 75
“Over time, these methodologies matured, using additional mesoderm induction growth factors from developmental biology, such as BMP4 and WNT3A (120, 137).”
BackgroundMethodInfluentialRight Ventricular Outflow Tract Repair with a Cardiac Biologic Scaffold
Wainwright, J. M., Hashizume, R., Fujimoto, K. L., Remlinger, N. T., Pesyna, C., Wagner, W. R., Tobita, K., Gilbert, T. W., & Badylak, S. F. (2012) · Cells Tissues Organs · doi:10.1159/000331400 · Cited by 77
Lian, X., Zhang, J., Zhu, K., Kamp, T. J., & Palecek, S. P. (2013) · Stem Cells · doi:10.1002/stem.1289 · Cited by 73
“Several extrinsic signaling pathways have been implicated in cardiac differentiation of hPSCs, including the transforming growth factor β (TGFβ) superfamily, broblast growth factor (FGF), insulin and insulin-like growth factor, and Wnt signaling [14–17].”
BackgroundZwi-Dantsis, L., Huber, I., Habib, M., Winterstern, A., Gepstein, A., Arbel, G., & Gepstein, L. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs096 · Cited by 78
Tan, Y., Kong, C., Chen, S., Cheng, S. H., Li, R. A., & Sun, D. B. (2011) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2011.09.007 · Cited by 78
Dual Reporter MESP1mCherry/w-NKX2-5eGFP/w hESCs Enable Studying Early Human Cardiac Differentiation
Den Hartogh, S. C., Schreurs, C., Monshouwer-Kloots, J. J., Davis, R. P., Elliott, D. A., Mummery, C. L., & Passier, R. (2015) · Stem Cells · doi:10.1002/stem.1842 · Cited by 74
Leung, R. K., Lin, Y., & Liu, Y. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00343-y · Cited by 79
A microparticle approach to morphogen delivery within pluripotent stem cell aggregates
Bratt‐Leal, A. M., Anh, N. T. V., Hammersmith, K. A., Singh, A. K., & McDevitt, T. C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.079 · Cited by 82
Aicher, A., Kollet, O., Heeschen, C., Liebner, S., Urbich, C., Ihling, C., Orlandi, A., Lapidot, T., Zeiher, A. M., & Dimmeler, S. (2008) · Circulation Research · doi:10.1161/circresaha.107.172718 · Cited by 73
Bai, H., Gao, Y., Arzigian, M., Wojchowski, D. M., Wu, W., & Wang, Z. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22410 · Cited by 82
Bekhite, M. M., Finkensieper, A., Binas, S., Müller, J. P., Wetzker, R., Figulla, H., Sauer, H., & Wartenberg, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.077594 · Cited by 77
“25 a ‘second’ Flk-1+ cell population with enriched cardiogenic as well as vasculogenic potential was identified (Yang et al., 2008).”
BackgroundInfluentialCalcium signalling of human pluripotent stem cell-derived cardiomyocytes
Li, S., Chen, G., & Li, R. A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.256495 · Cited by 76
“The cardiogenicity of PSCs is also highly influenced by a number of factors such as the EB size, media composition (e.g. serum, cytokines), the time and duration of differentiation, etc. Recently, various directed cardiac differentiation protocols (Yang et al. 2008; myocytes (C).”
BackgroundCardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models
Dambrot, C., Passier, R. C., Atsma, D. E., & Mummery, C. L. (2011) · Biochemical Journal · doi:10.1042/bj20101707 · Cited by 85
Stem Cell-based Tissue Engineering Approaches for Musculoskeletal Regeneration
Brown, P. T., Handorf, A. M., Jeon, W. B., & Li, W. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990350 · Cited by 86
Mizuno, M., Yamada, M., Mitamura, R., Ike, K., Toyama, K., & Seki, M. (2013) · Analytical Chemistry · doi:10.1021/ac303336f · Cited by 76
Development of the Cardiac Conduction System
Bhattacharyya, S., & Munshi, N. V. (2020) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037408 · Cited by 79
Devalla, H. D., & Passier, R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5457 · Cited by 75
Lu, T.-Y., Lin, B., Li, Y., Arora, A., Han, L., Cui, C., Coronnello, C., Sheng, Y., Benos, P. V., & Yang, L. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.019 · Cited by 72
Self-citationEffective Cardiac Myocyte Differentiation of Human Induced Pluripotent Stem Cells Requires VEGF
Ye, L., Zhang, S., Greder, L., Dutton, J., Keirstead, S. A., Lepley, M., Zhang, L., Kaufman, D., & Zhang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053764 · Cited by 73
“VEGF has been shown to promote KDR cardiovascular progenitor cell development from hESCs [33].”
BackgroundCrosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration
Chen, D., Xia, Y., Zuo, K., Wang, Y., Zhang, S., Kuang, D., Duan, Y., Zhao, X., & Wang, G. (2015) · Scientific Reports · doi:10.1038/srep16813 · Cited by 78
Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration
Yi, B. A., Wernet, O., & Chien, K. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40820 · Cited by 78
Miklas, J. W., Nunes, S. S., Sofla, A., Reis, L. A., Pahnke, A., Xiao, Y., Laschinger, C., & Radisic, M. (2014) · Biofabrication · doi:10.1088/1758-5082/6/2/024113 · Cited by 69
“Recent advances in the fields of stem cell biology [1–3] and”
BackgroundStem Cells for Heart Cell Therapies
Jing, D., Parikh, A., Canty, J. M., & Tzanakakis, E. S. (2008) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2008.0262 · Cited by 73
“6,7 Orlic et al .”
Xu, J., Liu, X., Chen, J., Zacharek, A., Cui, X., Savant‐Bhonsale, S., Liu, Z., & Chopp, M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00310.2008 · Cited by 75
The Wnt Antagonist Dickkopf-1 Increases Endothelial Progenitor Cell Angiogenic Potential
Smadja, D. M., d’Audigier, C., Weiswald, L., Badoual, C., Dangles‐Marie, V., Mauge, L., Evrard, S., Laurendeau, I., Lallemand, F., Germain, S., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213751 · Cited by 74
Epigenetic factors and cardiac development
van Weerd, J. H., Koshiba‐Takeuchi, K., Kwon, C. D., & Takeuchi, J. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr138 · Cited by 93
“They are also marked by Nkx2-5 or Flk1 and can be isolated from early developing embryos or differentiating pluripotent cells.(21,102,104) A recent trial of”
BackgroundKinnear, C., Chang, W. Y., Khattak, S., Hinek, A., Thompson, T., Rodrigues, D. C., Kennedy, K., Mahmut, N., Pasceri, P., Stanford, W. L., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0054 · Cited by 79
Id genes are essential for early heart formation
Cunningham, T. J., Yu, M. S., McKeithan, W. L., Spiering, S., Carrette, F., Huang, C.-T., Bushway, P. J., Tierney, M., Albini, S., Giacca, M., et al. (2017) · Genes & Development · doi:10.1101/gad.300400.117 · Cited by 74
“…model, BMP signaling directly activates Id1 transcription (Hollnagel et al. 1999; Katagiri et al. 2002; Korchynskyi and tenDijke 2002; Lopez-Rovira et al. 2002) and is both necessary and sufficient to induce cardiogenic mesoderm formation (Beppu et al. 2000; Yang et al. 2008; Paige et al. 2012).”
BackgroundFujimori, K., Matsumoto, T., Kisa, F., Hattori, N., Okano, H., & Akamatsu, W. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.024 · Cited by 72
“…from PSCs, EB formation has beenwidely used to initiate spontaneous differentiation toward the three germ lineages, as it is a relatively simple method for obtaining lineagecommitted cells in the mesodermal and endodermal lineages (Ng et al., 2005; Ogawa et al., 2013; Yang et al., 2008).”
MethodChal, J., Tanoury, Z. A., Oginuma, M., Moncuquet, P., Gobert, B., Miyanari, A., Tassy, O., Guevara, G., Hubaud, A., Bera, A. N., et al. (2018) · Development · doi:10.1242/dev.157339 · Cited by 72
“…need to be activated simultaneously, followed by a subsequent Wnt signaling inhibition step required to induce differentiation of the cardiomyocyte lineage (Laflamme et al., 2007; Lian et al., 2012; Naito et al., 2006; Nostro et al., 2008; Ueno et al., 2007; Yang et al., 2008; Zhang et al., 2008).”
BackgroundCells, Materials, and Fabrication Processes for Cardiac Tissue Engineering
Montero, P., Flandes‐Iparraguirre, M., Musquiz, S., Pérez-Araluce, M., Plano, D., Sanmartín, C., Orive, G., Gavira, J. J., Prósper, F., & Mazo, M. M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00955 · Cited by 74
“In both cases, early reports explored the addition of cardiac mesoderminducing growth factors, including FGF2, VEGF BMP4, Activin A, Wnt agonists (WNT3A) or antagonists (DKK1), amongst others (Yuasa et al., 2005; Kattman et al., 2006, 2011; Yang et al., 2008; Tran et al., 2009; James et al., 2010).”
BackgroundLipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism
Han, L., Huang, D., Wu, S., Liu, S., Wang, C., Sheng, Y., Lu, X., Broxmeyer, H. E., Wan, J., & Yang, L. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01162-4 · Cited by 75
Self-citationStem Cell Models of Cardiac Development and Disease
Musunuru, K., Domian, I. J., & Chien, K. R. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-103948 · Cited by 68
“…multipotent heart progenitors to specific differentiated cell types at the earliest stages of cardiogenesis (Cai et al. 2003, Laugwitz et al. 2005, Kattman et al. 2006, Moretti et al. 2006, Wu et al. 2006, Prall et al. 2007, Smart et al. 2007, Yang et al. 2008, Bu et al. 2009, Domian et al. 2009).”
BackgroundAdeno-associated Virus: A Key to the Human Genome?
Henckaerts, E., & Linden, R. M. (2010) · Future Virology · doi:10.2217/fvl.10.48 · Cited by 71
Self-citationCardiac Tissue Engineering and the Bioartificial Heart
Gálvez‐Montón, C., Prat‐Vidal, C., Roura, S., Soler‐Botija, C., & Bayés‐Genís, A. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.11.012 · Cited by 81
“of their strong capacity for expansion and subsequent differentiation into cardiomyocytes, endothelial cells and cardiac fibroblasts.(29,30) To avoid using this type of nonautologous cell and the consequent need for immunosuppression therapy, induced pluripotent stem cells have been developed from somatic human”
BackgroundDerivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
Narsinh, K., Narsinh, K. H., & Wu, J. C. (2011) · Circulation Research · doi:10.1161/circresaha.111.240374 · Cited by 76
High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias
Nazareth, E. J. P., Ostblom, J. E. E., Lücker, P. B., Shukla, S., Alvarez, M. M., Oh, S. K. W., Yin, T., & Zandstra, P. W. (2013) · Nature Methods · doi:10.1038/nmeth.2684 · Cited by 70
“To further support the primitive streak commitment of these lineages and to associate this early cell fate with functional commitment, we compared cardiac differentiation efficiency of ZAN11 and ZAN3 in an 18 day protocol 38 .”
Gaber, N., Gagliardi, M., Patel, P., Kinnear, C., Zhang, C., Chitayat, D. A., Shannon, P. T., JAEGGI, E. T., Tabori, U. Y., Keller, G. M., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.022 · Cited by 75
“hPSCs provide an excellent in vitro cellularmodel to study the effect of prenatal factors during cardiac differentiation, particularly because current cardiac differentiation protocols yield cardiac lineages that are in fetal stages of maturity.(4,5,14) Thus, our findings provide important biological insights into LV…”
BackgroundMethodInfluentialSelf-citationPei, F., Jiang, J., Bai, S., Cao, H., Tian, L., Zhao, Y., Yang, C., Dong, H., & Ma, Y. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.01.006 · Cited by 66
Baldassarre, A. D., Cimetta, E., Bollini, S., Gaggi, G., & Ghinassi, B. (2018) · Cells · doi:10.3390/cells7060048 · Cited by 78
“[45] established a three-step serum-free protocol characterized by subsequent supplementation of several cytokines (Activin A, BMP4, VEGF, DKK1, and bFGF) that resulted in a more efficient differentiation of the EBs into CMs.”
BackgroundMethodSIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development
Skelton, R. J. P., Costa, M., Anderson, D. J., Bruveris, F., Finnin, B. W., Koutsis, K., Arasaratnam, D., White, A. J., Rafii, A., Ng, E., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.04.016 · Cited by 83
Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
Acimovic, I., Vilotic, A., Pesl, M., Lacampagne, A., Dvorak, P., Rotrekl, V., & Meli, A. C. (2014) · BioMed Research International · doi:10.1155/2014/512831 · Cited by 66
“In the present work, we aim at focusing on the protocols for differentiation of hPSCs into functional cardiomyocytes in vitro as well as achievements in the heart disease modelling and drug testing on the patient-specific iPSC-derived cardiomyocytes (iPSC-CMs).”
MethodSmall molecules and small molecule drugs in regenerative medicine
Lu, B., & Atala, A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.011 · Cited by 72
Blood and Lymphatic Vessel Formation
Bautch, V. L., & Caron, K. M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008268 · Cited by 84
“5 mouse embryos, and Vogeli et al. lineage traced single cells in the zebrafish embryo to provide rigorous proof for a Cite this article as Cold Spring Harb Perspect Biol 2015;7:a008268 3 link between the lineages (Choi et al. 1998; Huber et al. 2004; Vogeli et al. 2006; Yang et al. 2008).”
BackgroundWang, J., Chen, A., Lieu, D. K., Karakikes, I., Chen, G., Keung, W., Chan, C. W., Hajjar, R. J., Costa, K. D., Khine, M., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.039 · Cited by 69
“By contrast, hESC-CM clusters differentiated in vitro using either embryoid body (EB) formation [19] or even directed cardiac differentiation [5] are heterogenous, containing a mixed population of V, atrial and pacemaker derivatives, and randomly organized, and therefore not representative of native conditions [19,20].”
BackgroundChristoforou, N., Oskouei, B. N., Esteso, P., Hill, C., Zimmet, J. M., Bian, W., Bursac, N., Leong, K. W., Hare, J. M., & Gearhart, J. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011536 · Cited by 70
“cardiac improvement following myocardial infarction”
Nano‐Enabled Approaches for Stem Cell‐Based Cardiac Tissue Engineering
Kharaziha, M., Memic, A., Akbari, M., Brafman, D. A., & Nikkhah, M. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600088 · Cited by 66
Kobayashi, H., Tohyama, S., Ichimura, H., Ohashi, N., Chino, S., Soma, Y., Tani, H., Tanaka, Y., Yang, X. H., Shiba, N., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.064876 · Cited by 69
“1 Numerous studies, 2–5 including those on the generation and metabolic selection of hiPSC-CMs, have made it practical to generate a large number of CMs. 13 On the basis of these animal studies, clinical studies involving the transplantation of human pluripotent stem cell–derived cardiac tissue…”
Combinatorial Extracellular Matrices for Human Embryonic Stem Cell Differentiation in 3D
Yang, F., Cho, S.-W., Son, S. M., Hudson, S. P., Bogatyrev, S., Keung, L., Kohane, D. S., Langer, R., & Anderson, D. G. (2010) · Biomacromolecules · doi:10.1021/bm100357t · Cited by 68
Cardiac tissue engineering and regeneration using cell-based therapy
Alrefai, M., Murali, D., Paul, A., Ridwan, K., Connell, J., & Shum‐Tim, D. (2015) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s54204 · Cited by 80
“Differentiation protocols for human EmSCs to cardiomyocytes involve adding bone morphogenetic protein 4 (BMP4) and recombinant human activin A to induce the cardiac mesoderm to reproduce the main foundations of embryonic development.(18,37,38) Laflamme et al(18) produced cardiomyocyte populations with over 50% cardiac…”
Wang, J., Cui, C., Nan, H., Yu, Y., Xiao, Y., Poon, E. N.-Y., Yang, G., Wang, X., Wang, C., Li, L., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08777 · Cited by 72
Ardehali, R., Ali, S. R., Inlay, M. A., Abilez, O. J., Chen, M. Q., Blauwkamp, T. A., Yazawa, M., Gong, Y., Nusse, R., Drukker, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220832110 · Cited by 68
“To determine whether cardiovascular progenitors develop from a subpopulation of differentiating hESCs that expresses one or more of these surface markers, EBs were analyzed for expression of ROR2, CD13, KDR, and PDGFR-α after 5 d of differentiation.”
MethodInfluentialHarnessing organs-on-a-chip to model tissue regeneration
Tavakol, D. N., Fleischer, S., & Vunjak-Novakovic, G. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.05.008 · Cited by 63
Scalise, M., Marino, F., Salerno, L., Cianflone, E., Molinaro, C., Salerno, N., Angelis, A. D., Viglietto, G., Urbanek, K., & Torella, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413180 · Cited by 77
“Nowadays, it has been also used for EB cardiac differentiation [124,127].”
BackgroundEngineering the human pluripotent stem cell microenvironment to direct cell fate
Hazeltine, L. B., Selekman, J. A., & Palecek, S. P. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.002 · Cited by 66
“…method involving EB exposure to BMP-4, FGF2, Activin A, VEGF, and DKK-1 in a specific temporal manner was modified in another study to induce erythromyeloid and, more specifically, B-cell lymphopoiesis of hiPSCs following hematopoietic commitment (Carpenter et al., 2011, Yang et al., 2008).”
BackgroundMethodProgenitor cell therapy for heart disease
Gonzales, C., & Pedrazzini, T. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.09.006 · Cited by 80
Cordeiro, J. M., Nesterenko, V. V., Sicouri, S., Goodrow, R. J., Treat, J. A., Desai, M., Wu, Y., Doss, M. X., Antzelevitch, C. N., & Diego, J. M. D. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.014 · Cited by 75
“The human iPS cell line IMR-90-C4 (WiCell, Madison, WI, USA), reprogrammed with Oct4, Sox2, Lin28 and Nanog as described previously [24,25] was maintained in serum-free, feeder-free conditions with mTeSR1 media (Stem Cell Technologies, Vancouver, Canada) on BD MatrigelTM (BD Biosciences, San Jose, CA) coated dishes fo…”
MethodFrom fibroblast cells to cardiomyocytes: direct lineage reprogramming
Yang, L. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt42 · Cited by 68
Self-citationCapturing the biology of disease severity in a PSC-based model of familial dysautonomia
Zeltner, N., Fattahi, F., Dubois, N. C., Saurat, N. G., Lafaille, F. G., Shang, L., Zimmer, B., Tchieu, J. H., Soliman, M. A., Lee, G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4220 · Cited by 70
Yamagishi, H., Srivastava, D., Keller, B. B., Hs, B., Markwald, R. R., & Nakanishi, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-54628-3 · Cited by 69
Liu, J., Li, Y., Lin, B., Sheng, Y., & Yang, L. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.07.023 · Cited by 68
“Therefore, the baseline CM differentiation efficiency was lower when compared with the presence of Wnt inhibitor (Yang et al., 2008) (Figure 1F).”
InfluentialSelf-citationGenome-wide identification of endothelial cell–enriched genes in the mouse embryo
Takase, H., Matsumoto, K., Yamadera, R., Kubota, Y., Otsu, A., Suzuki, R., Ishitobi, H., Mochizuki, H., Kojima, T., Takano, S., et al. (2012) · Blood · doi:10.1182/blood-2011-12-398156 · Cited by 67
Lanier, M., Schade, D., Willems, E., Tsuda, M., Spiering, S., Kalisiak, J., Mercola, M., & Cashman, J. R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2010223 · Cited by 67
Hanson, K. P., Jung, J. P., Tran, Q. A., Hsu, S.-P. P., Iida, R., Ajeti, V., Campagnola, P. J., Eliceiri, K. W., Squirrell, J. M., Lyons, G. E., et al. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0316 · Cited by 73
Sasaki, K., Makiyama, T., Yoshida, Y., Wuriyanghai, Y., Kamakura, T., Nishiuchi, S., Hayano, M., Harita, T., Yamamoto, Y., Kohjitani, H., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164795 · Cited by 65
Induced pluripotent stem cell–derived cardiomyocytes in studies of inherited arrhythmias
Priori, S. G., Napolitano, C., Di Pasquale, E., & Condorelli, G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62838 · Cited by 65
Haraguchi, Y., Matsuura, K., Shimizu, T., Yamato, M., & Okano, T. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1761 · Cited by 63
“…medicine and tissue engineering, since they are capable of unlimited proliferation under optimal culture conditions and can differentiate into various types of cells, including beating cardiomyocytes, in vitro using several methods (Kehat et al., 2001; Mummery et al., 2003; Yang et al., 2008).”
MethodGao, L. R., Zhang, N. K., Ding, Q. A., Chen, H. Y., Hu, X., Jiang, S., Li, T. C., Chen, Y., Wang, Z. G., Yang, Y., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x662444 · Cited by 66
“(hESCs) have been successfully converted in vitro into functional cardiomyocytes, and transfer of such cells into ischemic animal models has shown successful engraftment (22,24,62,63).”
BackgroundThe case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening
Khan, J. M., Lyon, A. R., & Harding, S. E. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02118.x · Cited by 63
“…(Burridge et al., 2011; Xu et al., 2012), manipulation of Activin/ Nodal and Wnt signalling pathways as mentioned earlier (Laflamme et al., 2007; Yang et al., 2008; Kattman et al., 2011; Ren et al., 2011), and supplementing the culture media with chemical promoters of cardiac differentiation…”
BackgroundInfluentialMacAskill, M. G., Saif, J., Condie, A., Jansen, M. A., MacGillivray, T., Tavares, A., Fleisinger, L., Spencer, H. L., Besnier, M., Martin, E., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.03.017 · Cited by 68
Bioengineering adult human heart tissue: How close are we?
Mills, R. J., & Hudson, J. E. (2019) · APL Bioengineering · doi:10.1063/1.5070106 · Cited by 68
Fibronectin mediates mesendodermal cell fate decisions
Cheng, P., Andersen, P., Hassel, D., Kaynak, B. L., Limphong, P., Juergensen, L., Kwon, C., & Srivastava, D. (2013) · Development · doi:10.1242/dev.089052 · Cited by 65
“Using an established combination of activin A and BMP4 (Kattman et al., 2006; Yang et al., 2008), we induced precardiac mesoderm (Bry+ Mesp1+) at day 4 of differentiation in mESNkx2.”
MethodKadari, A., Mekala, S. R., Wagner, N., Malan, D., Köth, J., Doll, K., Stappert, L., Eckert, D., Peitz, M., Matthes, J., et al. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9564-6 · Cited by 72
“72 °C for 45 s; followed by a single cycle of 72 °C for 5 min using the primers [37] given below.”
MethodType I interferon response impairs differentiation potential of pluripotent stem cells
Eggenberger, J., Blanco-Melo, D., Panis, M., Brennand, K., & tenOever, B. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812449116 · Cited by 69
Pahnke, A., Conant, G., Huyer, L. D., Zhao, Y., Feric, N. T., & Radisic, M. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.060 · Cited by 64
“By including the Wnt inhibitor dickkopf-related protein 1 (DKK1)—a Wnt inhibitor that binds LRP6 [23,24]—during the stage of cardiac mesoderm induction and specification, the CM yield was increased to >50% [25].”
BackgroundBan, K., Bae, S., & Yoon, Y. (2017) · Theranostics · doi:10.7150/thno.19427 · Cited by 70
In vitro cardiomyogenic potential of human amniotic fluid stem cells
Guan, X., Delo, D. M., Atala, A., & Söker, S. (2010) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.308 · Cited by 63
“Beating cardiomyocytes can spontaneously derived from these pluripotent cells(Kuzmenkin et al., 2009; Laflamme et al., 2007; Yang et al., 2008).”
BackgroundFuerstenau-Sharp, M., Zimmermann, M. E., Stark, K. J., Jentsch, N., Klingenstein, M., Drzymalski, M. A., Wagner, S., Maier, L. S., Hehr, U., Baessler, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126596 · Cited by 67
Cardiac Applications for Human Pluripotent Stem Cells
Shiba, Y., Hauch, K. D., & Laflamme, M. A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788923804 · Cited by 72
“These temporally distinct populations are also present in hESC derivatives generated using the Keller induction protocol, and, at 5-6 days post-induction, they can be distinguished based on their differential expression of KDR and the stem cell marker c-Kit [74].”
BackgroundMethodInfluentialiPSC technology-Powerful hand for disease modeling and therapeutic screen
Kim, C. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.5.100 · Cited by 70
“In 2008, Keller’s group reported the involvement of BMP4 and DKK/Wnt signaling (14)”
BackgroundAdvances in understanding the mechanism of zebrafish heart regeneration
Kikuchi, K. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.07.003 · Cited by 68
“…2003; Bu et al., 2009; Chong et al., 2011; Ellison et al., 2013; Goumans et al., 2007; Hierlihy et al., 2002; Laugwitz et al., 2005; Matsuura et al., 2004; Messina et al., 2004; Oh et al., 2003; Pfister et al., 2010; Smith et al., 2007; Uchida et al., 2013; van Berlo et al., 2014; Ye et al., 2012).”
Kong, C.-W., Akar, F., & Li, R. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-03-0189 · Cited by 62
“As an example, specification of human tripotent KDRlow/c-kitneg cardiovascular progenitors (CP) into CMs has been reported (19).”
BackgroundDeconstructing Pancreas Development to Reconstruct Human Islets from Pluripotent Stem Cells
McKnight, K. D., Wang, P., & Kim, S. K. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.003 · Cited by 62
“Such an approach was recently used to isolate cardioblast-like cells from ESC cultures by Keller and colleagues (Yang et al., 2008).”
BackgroundMethodResultInfluentialCardiac commitment of primate embryonic stem cells
Leschik, J., Stefanovic, S., Brinon, B., & Pucéat, M. (2008) · Nature Protocols · doi:10.1038/nprot.2008.116 · Cited by 64
Discovering Small Molecules that Promote Cardiomyocyte Generation by Modulating Wnt Signaling
Ni, T. T., Rellinger, E. J., Mukherjee, A., Xie, S., Stephens, L., Thorne, C. A., Kim, K., Hu, J., Lee, E. N., Marnett, L. J., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.09.015 · Cited by 65
“Recent studies have established that inhibition of the canonical Wnt pathway after the germ layer cell formation is necessary to promote cardiomyocyte differentiation from human cardiovascular stem cells (Yang et al., 2008).”
BackgroundHiguchi, A., Ku, N.-J., Tseng, Y.-C., Pan, C.-H. P., Li, H.-F., Kumar, S. S., Ling, Q., Chang, Y., Alarfaj, A. A., Munusamy, M. A., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.100 · Cited by 65
Expanding the CRISPR Toolbox with ErCas12a in Zebrafish and Human Cells
Wierson, W. A., Simone, B. W., WareJoncas, Z., Mann, C. M., Welker, J. M., Kar, B., Emch, M. J., Friedberg, I., Gendron, W. A. C., Barry, M. A., et al. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0026 · Cited by 64
Christoforou, N., Liau, B., Chakraborty, S., Chellappan, M. K., Bursac, N., & Leong, K. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065963 · Cited by 66
“These progenitors represent a dynamic state during ES cell differentiation, and for murine cells are typically isolated after differentiation day 5 when transcripts coding for early cardiac transcription factors are first detected [10,29,49,51].”
BackgroundApplication of mesenchymal stem cell sheet to treatment of ischemic heart disease
Chang, D., Fan, T., Gao, S., Jin, Y., Zhang, M., & Ōno, M. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02451-1 · Cited by 65
“Their differentiation can be regulated by culture conditions in vitro by cytokine-based or small molecule-based methods [59, 60].”
Ban, K., Wile, B. M., Kim, S., Park, H., Byun, J., Cho, K.-W., Saafir, T. B., Song, M.-K., Yu, S. P., Wagner, M. B., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004228 · Cited by 63
Cui, G., Luk, S. C. W., Li, R. A., Chan, K. K., Lei, S. W., Wang, L., Shen, H., Leung, G., & Lee, S. M. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000161 · Cited by 61
“org), and they were induced as previously described.(25,26) This differentiation protocol yields more than 90% spontaneous beating cardiospheres.”
MethodYap, L., Wang, J., Moreno‐Moral, A., Chong, L. Y., Sun, Y., Harmston, N., Wang, X., Chong, S. Y., Vanezis, K., Öhman, M. K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.083 · Cited by 63
Cai, Q., Liao, W., Xue, F., Wang, X., Zhou, W., Li, Y., & Zeng, W. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.021 · Cited by 71
BAF60 A, B, and Cs of muscle determination and renewal
Puri, P., & Mercola, M. A. (2012) · Genes & Development · doi:10.1101/gad.207415.112 · Cited by 67
“5, Isl-1, and Tbx5 (Yang et al. 2008; Blin et al. 2010).”
Tanwar, V., Bylund, J. B., Hu, J., Yan, J., Walthall, J. M., Mukherjee, A., Heaton, W. H., Wang, W.-D., Potet, F., Rai, M., et al. (2014) · Stem Cells · doi:10.1002/stem.1703 · Cited by 59
Modeling Timothy Syndrome with iPS Cells
Yazawa, M., & Dolmetsch, R. E. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9444-x · Cited by 61
“Although the efficiency of this technique is relatively low compared to methods using EB or monolayer cultures with defined growth factor cocktails(22, 23), we successfully observed three major types of myocytes in control and TS cells at day 40–60 after induction of differentiation: embryonic nodal-, atrial- and vent…”
Martins, A. M., Vunjak-Novakovic, G., & Reis, R. L. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9487-7 · Cited by 59
Geometry and force control of cell function
Freytes, D. O., Wan, L. Q., & Vunjak‐Novakovic, G. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22355 · Cited by 68
“The efforts to derive cardiac cell populations from human embryonic stem cells (hESCs) [Yang et al., 2008] and to develop effective tissue engineering systems [Radisic et al., 2004b; Zimmermann et al., 2006; Tandon et al., 2009] have been guided by these developmental ‘‘blueprints.’’”
Background
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.